Literature DB >> 23128060

Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility.

M J Maisels1, H Yang.   

Abstract

We describe the use of tin-mesoporphyrin (SnMP) in the treatment of an infant with Rh hemolytic disease. The infant's hyperbilirubinemia responded to phototherapy but every time the phototherapy was discontinued, the serum bilirubin rebounded and repeat phototherapy was necessary. A single intramuscular dose of SnMP on day 18 eliminated the need for further phototherapy and allowed us to discharge this infant.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23128060     DOI： 10.1038/jp.2012.45

Source DB:  PubMed          Journal:  J Perinatol        ISSN： 0743-8346            Impact factor:   2.521


  2 in total

1.  Exchange transfusion for hemolytic hyperbilirubinemia: could some be averted by emergent administration of an inhibitor of bilirubin production?

Authors:  Susan E Wiedmeier; Timothy M Bahr; Robin K Ohls; Thomas R Christensen; Vickie L Baer; Sarah J Ilstrup; Kelly Cail; Robert D Christensen
Journal:  J Perinatol       Date:  2020-07-15       Impact factor: 2.521

Review 2.  Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review.

Authors:  Prakar Poudel; Sudhir Adhikari
Journal:  Int J Pediatr       Date:  2022-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.